Tag: optica

Neurology

Near-fatal primary manifestation of anti-aquaporin 4-positive neuromyelitis optica spectrum disorder survived without neurological sequelae: A case report

Newsemia
Neuromyelitis optica spectrum disorders (NMOSD) are rare immune-mediated demyelinating diseases of the central nervous system (CNS). These include encephalitis of the dorsal medulla oblongata leading...
Latest News

Low Myo‐inositol indicating astrocytic damage in a case series of neuromyelitis optica

Newsemia
Ciccarelli, O; Thomas, DL; DeVita, E; Wheeler-Kingshott, CAM; Kachramanoglou, C; Kapoor, R; Leary, S; … Thompson, AJ; + view all Ciccarelli, O; Thomas, DL; DeVita,...
Latest News

Samenvatting: Resultaten van Fase III SAkuraSky-studie voor Chugai’s Satralizumab bij Neuromyelitis Optica Spectrumstoornis Gepubliceerd in The New England Journal of Medicine Online

Newsemia
TOKYO–(BUSINESS WIRE)–Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) heeft aangekondigd dat de resultaten van de SAkuraSky-studie (NCT02028884), een wereldwijde fase III klinische studie van satralizumab (ontwikkelingscode:...
Latest News

Positive Phase III Results for Genentech’s Satralizumab in Neuromyelitis Optica Spectrum Disorder Published in the New England Journal of Medicine

Newsemia
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that data from SAkuraSky, a pivotal Phase...
Latest News

Genentech to Present Pivotal Data for Satralizumab in Neuromyelitis Optica Spectrum Disorder and Six-year Ocrevus (Ocrelizumab) Data in Multiple Sclerosis at ECTRIMS

Newsemia
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that new data across its neuroscience portfolio...
Latest News

Drug reduces risk of relapse with neuromyelitis optica spectrum disorder, study shows

Newsemia
The drug eculizumab, a synthetic antibody that inhibits the inflammatory response, significantly reduced the risk of relapse with neuromyelitis optica spectrum disorder. Source link...
Neurology

Two cases of late-onset neuromyelitis optica spectrum disorder initially presenting with isolated cerebral white matter lesions

Newsemia
Neuromyelitis optica (NMO) is an autoimmune inflammatory central nervous system disorder typically associated with longitudinally extensive transverse myelitis (LETM) and optic neuritis. The serum autoantibody...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy